Submit your email to push it up the queue
Alliqua BioMedical, Inc., a prominent player in the biotechnology industry, is headquartered in the United States. Founded in 2011, the company has established itself as a leader in advanced wound care and regenerative medicine, focusing on innovative solutions that enhance patient outcomes. Alliqua's core offerings include a range of proprietary products, such as hydrogel dressings and bioengineered tissue matrices, which are designed to promote healing and tissue regeneration. These unique products set Alliqua apart in a competitive market, addressing the needs of healthcare providers and patients alike. With a commitment to research and development, Alliqua BioMedical has achieved significant milestones, positioning itself as a trusted name in the industry. Its dedication to quality and innovation continues to drive its success in the evolving landscape of medical technology.
How does Alliqua BioMedical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Alliqua BioMedical, Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Alliqua BioMedical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. It is important to note that Alliqua BioMedical, Inc. is a merged entity, and any potential emissions data or climate commitments may be cascaded from its corporate family. However, no specific information regarding such data or initiatives has been provided. In the context of the industry, companies are increasingly focusing on sustainability and carbon reduction strategies, often setting ambitious targets aligned with global climate goals. Alliqua BioMedical, Inc. may need to establish clear climate commitments to align with these industry standards and expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alliqua BioMedical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.